Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

Addgene
Two rare disease-associated Tyk2 variants are catalytically impaired but signaling competent.
Li Z, Gakovic M, Ragimbeau J, Eloranta ML, Ronnblom L, Michel F, Pellegrini S
J Immunol. 2013 Mar 1;190(5):2335-44. doi: 10.4049/jimmunol.1203118. Epub 2013 Jan 28.
PubMed Article

Plasmids from Article

ID Plasmid Purpose
139350pRC/CMV-TYK2P1104A-VSVExpression of the TYK2-P1104A variant, rs34536443
139351pRC/CMV-TYK2VF/PA-VSVExpression of the double mutant of TYK2-V678F-P1104A
139357pRC/CMV-JAK1K908E-VSVExpression of kinase-dead JAK1-K908E protein
139358pRC/CMV-JAK1P1084A-VSVExpression of the catalytically impaired JAK1-P1084A mutant (corresponding to TYK2-P1104A)

Antibodies from Article